• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Cloud Market
Cloud News
Cloud Stocks
  • Cloud Market
  • Cloud News
  • Cloud Stocks
cloud-investing

DNAnexus and Sapio Sciences Team Up for Seamless Integration of Laboratory Information Management System and Cloud Bioinformatics Solution

Vivien Diniz
Jan. 28, 2016 09:52AM PST
Cloud Investing

DNAnexus Inc., announced the integration of its cloud-based genomics platform with Sapio Sciences’ Exemplar Next Generation Sequencing (NGS) Laboratory Information Management System (LIMS) solution for clinical and research labs.

DNAnexus Inc., announced the integration of its cloud-based genomics platform with Sapio Sciences’ Exemplar Next Generation Sequencing (NGS) Laboratory Information Management System (LIMS) solution for clinical and research labs. Organizations and their labs now have a cloud-based, sample-to-answer tracking solution that enables them to optimize their operations by reducing costs, improving accuracy, and ensuring quality control.
According to the press release:

Sapio Sciences is at the forefront of genomics/genetics LIMS implementations. Leading laboratories use Exemplar NGS LIMS to balance deadlines and shrink budgets by tracking their NGS workflows from request through processing and analysis. The system supports CLIA compliant workflows, instrument integrations, support for automation, and consumables management. The DNAnexus Platform is a recognized leader of cloud-based data security, compliance, and sharing of genomic data and tools. The combination of DNAnexus and Sapio Sciences allows for the laboratory management process to seamlessly integrate with the bioinformatics operations, enabling secure scalability, flexible workflows, and tertiary analysis.

Richard Daly, CEO, DNAnexus commented:

The flexibility of Exemplar NGS LIMS is a great complement to the DNAnexus Platform, making Sapio Sciences an ideal partner. Sapio and DNAnexus share a common goal of helping labs and research facilities focus on the analysis and interaction with genomic data to advance medical discovery, rather than infrastructure management. Scientists in research and clinical labs now have the freedom to customize their laboratory and bioinformatics solutions based on internal requirements while minimizing costs associated with infrastructure and maintenance.

Click here to view the press release. 

cloud-investing
The Conversation (0)

Go Deeper

AI Powered
A floating DNA double helix above a hand with a blue background.

Top 4 NASDAQ Genetics Stocks (Updated January 2026)

Life Science Outlook: World Edition

Life Science Outlook: World Edition

Latest News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Cloud Investing Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES